According to our systematic review, there were 5 aberrantly methylated genes (including CDKN2A, MGMT, CDH13, RUNX3 and APC) associated with the pathological types of NSCLC, and the remaining 11 gene methylation events showed no significant difference between AC and SCC. The gene discussed is CDH13; the disease is non-small cell lung carcinoma.